Detalhe da pesquisa
1.
A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.
Mov Disord
; 37(5): 1088-1093, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218231
2.
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
Curr Med Res Opin
; 39(7): 1021-1030, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272079
3.
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.
CNS Drugs
; 37(4): 337-350, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961650
4.
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
J Clin Psychiatry
; 84(5)2023 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672016
5.
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison.
Neuropsychiatr Dis Treat
; 19: 1409-1416, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313228
6.
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension.
Schizophr Res
; 248: 271-278, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115192
7.
A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia.
Eur Neuropsychopharmacol
; 61: 4-14, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704951
8.
Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate.
Neuropsychiatr Dis Treat
; 17: 1881-1892, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140772
9.
A Noninterventional Cohort Study Assessing Time to All-Cause Treatment Discontinuation After Initiation of Aripiprazole Once Monthly or Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-Onset Schizophrenia.
Prim Care Companion CNS Disord
; 23(5)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592798
10.
The burden of disease in early schizophrenia - a systematic literature review.
Curr Med Res Opin
; 37(1): 109-121, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095689
11.
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies.
Neuropsychiatr Dis Treat
; 15: 1593-1604, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354275
12.
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment.
Neuropsychiatr Dis Treat
; 15: 2325-2338, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616148
13.
The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies.
Neuropsychiatr Dis Treat
; 15: 1659-1669, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296992
14.
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.
J Affect Disord
; 241: 425-432, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145513
15.
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder.
J Affect Disord
; 227: 649-656, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174738
16.
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.
Int J Bipolar Disord
; 6(1): 14, 2018 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29886522
17.
Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.
Patient Prefer Adherence
; 12: 63-70, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29379273
18.
Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole.
Neuropsychiatr Dis Treat
; 13: 1125-1129, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461748
19.
Development of a stated-preference instrument to prioritize treatment goals in recent onset schizophrenia.
Curr Med Res Opin
; 33(12): 2129-2136, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945106
20.
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
J Clin Psychiatry
; 78(3): 324-331, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146613